<DOC>
	<DOCNO>NCT00446069</DOCNO>
	<brief_summary>The purpose study determine effect EgaletÂ® Morphine daily compare MST Continus twice daily pain intensity use rescue medication break pain 2 week treatment patient pain due cancer .</brief_summary>
	<brief_title>A Efficacy Safety Trial Controlled Release ( CR ) Morphine Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<criteria>The patient stable strong opioid use equipotent 30240 mg oral morphine sulphate daily minimum 2 week prior enter runin phase . The patient opioidsensitive pain cause active cancer . The patient age minimum 18 year . The patient life expectancy le 2 month . The patient receive chemotherapy radiation therapy le 4 week prior enter runin phase Patients medical condition contraindicate morphine treatment The patient hepatic disease impair kidney function The patient take monoamine oxidase inhibitor ( MAOIs ) take MAOI within two week prior enter baseline . The patient take opioid agonist antagonist , zidovudine cimetidine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>